Argatroban

FDA Approved: * June 30, 2000
Pharm Company: * ENCYSIVE
Category: Blood Thinner (Anticoagulant)

Argatroban is an anticoagulant that is a small molecule direct thrombin inhibitor.[2] In 2000, argatroban was licensed by the Food and Drug Administration (FDA) for prophylaxis or treatment of thrombosis in patients with heparin-induced thrombocytopenia (HIT). In 2002, it was approved for use during percutaneous coronary interventions in patients who have HIT or are at risk for developing it. In 2012, it was approved by the MHRA in the UK for anticoagulation in patients with... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Argatroban 100 mg/ml Intravenous Injection, Solution
NDC: 0007-4407
Labeler:
Glaxosmithkline LLC
Argatroban 100 mg/ml Intravenous Injection, Solution
NDC: 0078-0930
Labeler:
Novartis Pharmaceuticals Corporation
Argatroban 250 mg/2.5ml Intravenous Injection
NDC: 0143-9288
Labeler:
West-ward Pharmaceuticals Corp
Argatroban 50 mg/50ml Intravenous Injection
NDC: 0143-9377
Labeler:
Hikma Pharmaceuticals USA Inc.
Argatroban 50 mg/50ml Intravenous Injection
NDC: 0143-9559
Labeler:
West-ward Pharmaceuticals Corp
Argatroban 250 mg/2.5ml Intravenous Injection
NDC: 0143-9674
Labeler:
West-ward Pharmaceutical Corp
Argatroban 100 mg/ml Intravenous Injection, Solution
NDC: 0409-1140
Labeler:
Hospira, Inc.
Argatroban 1 mg/ml Intravenous Injection, Solution
NDC: 0703-0020
Labeler:
Teva Parenteral Medicines, Inc.
Argatroban 125 mg/125ml Intravenous Solution
NDC: 0781-3285
Labeler:
Sandoz Inc
Argatroban 1 mg/ml Intravenous Injection, Solution
NDC: 0781-3314
Labeler:
Sandoz Inc

Related Brands

Drugs with the same active ingredients